There were more male patients with complications of diabetic peripheral neuropathy and diabetic nephropathy, more male participants treated with insulin, and fewer male participants treated with oral hypoglycemic agents in the probable sarcopenia group than in the control group; however, such differences were not observed in the female subgroup. This evidence concerns the gene INS and diabetic kidney disease.